Cargando…
Inhibition of neointimal hyperplasia in a rabbit vein graft model following non-viral transfection with human iNOS cDNA
Vein graft failure caused by neointimal hyperplasia (IH) after coronary artery bypass grafting with saphenous veins is a major clinical problem. The lack of safe and efficient vectors for vascular gene transfer has significantly hindered progress in this field. We have developed a Receptor-Targeted...
Autores principales: | Meng, Q-H, Irvine, S, Tagalakis, A D, McAnulty, R J, McEwan, J R, Hart, S L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3795475/ https://www.ncbi.nlm.nih.gov/pubmed/23636244 http://dx.doi.org/10.1038/gt.2013.20 |
Ejemplares similares
-
Pretreatment with intraluminal rapamycin nanoparticle perfusion inhibits neointimal hyperplasia in a rabbit vein graft model
por: Liu, Kai, et al.
Publicado: (2010) -
Rapamycin-loaded nanoparticles for inhibition of neointimal hyperplasia in experimental vein grafts
por: Zou, Junjie, et al.
Publicado: (2011) -
Patient-Specific, Multi-Scale Modeling of Neointimal Hyperplasia in Vein Grafts
por: Donadoni, Francesca, et al.
Publicado: (2017) -
Retraction: Rapamycin-loaded nanoparticles for inhibition of neointimal hyperplasia in experimental vein grafts
por: Zou, Junjie, et al.
Publicado: (2012) -
The effects of PPARγ agonist rosiglitazone on neointimal hyperplasia in rabbit carotid anastomosis model
por: Guzeloglu, Mehmet, et al.
Publicado: (2012)